View printer-friendly version
« Back
May 09, 2014 8:00 a.m.
Teva to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

JERUSALEM--(BUSINESS WIRE)--May 9, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Bank of America Merrill Lynch 2014 Health Care Conference. Eyal Desheh, EVP & CFO will present on Tuesday, May 13, 2014 at 12:00 PM PT.

What: Teva Presentation at the Bank of America Merrill Lynch Healthcare Conference

Who: Eyal Desheh, EVP and CFO,

Teva Pharmaceutical Industries Ltd.

When: Tuesday, May 13, 2014

Where: www.tevapharm.com

How: Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.

Source: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin C. Mannix, 215-591-8912
or
Ran Meir, 215-591-3033
or
Israel
Tomer Amitai, 972 (3) 926-7656
or
PR:
Israel
Iris Beck Codner, 972 (3) 926-7246
or
United States
Denise Bradley, 215-591-8974